Class II
Terminated
Ranitidine 150 mg tablets, 24 count bottles, NDC 37808-196-01.
- Company
- Aaa Pharmaceutical, Inc.
- Recall Initiated
- December 26, 2019
- Posted
- January 15, 2020
- Recall Number
- D-0645-2020
- Voluntary / Mandated
- Voluntary: Firm initiated
- Quantity
- 34,272 (24-count bottles)
- Firm Location
- Lumberton, NJ, United States
Reason for Recall
CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API
Distribution
Product was distributed to one consignee who may have distributed the product further to their retail stores.
Lot / Code Info
P134458, Sept 2020 P134943, Aug 2020 P135840, Aug, 2020 P136622, April 2021 P136871, April 2021 P137347, April 2021 P137424, April 2021
More recalls by Aaa Pharmaceutical, Inc.
Other recent Class II Drug recalls
Vista Tears Polyethylene Glycol 400 0.4% w/v, Propylene Glycol 0.3% w/v Eye Drops, Dry Eye Relief, L...
Wizcure Pharmaa Private Limited
· Mar 4, 2026
Amantadine HCl, Capsules, UPS, 100 mg, 50 Capsules (5 x 10) unit dose, Rx Only, Manufactured for: Av...
Avkare
· Mar 4, 2026
Agebox iKids-Growth (Day Formula) capsules, 60-count bottles, Manufactured Exclusively For: AGEBOX I...
Agebox
· Mar 4, 2026
Adbry, (tralokinumab-ldrm) injection, 300 mg/2mL, Packaged as a) 1 x Single dose Autoinjector, SAMPL...
Leo Pharma Inc
· Mar 4, 2026
Pro Numb Tattoo Numbing Spray, For Sensitive Skin, 4% Lidocaine, [1FL OZ/28.4 ML or 4 oz/120 mL] per...
Pro Numb Tattoo Numbing Spray Llc
· Feb 18, 2026